Intelligent Imaging Innovations GmbH

Their core work

Intelligent Imaging Innovations GmbH is a German SME based in Göttingen that develops and supplies specialized scientific imaging systems for life sciences research. In both their H2020 engagements they participated as third-party contributors — a role typically taken by companies that host visiting researchers or provide instrumentation to academic training networks without being formal beneficiaries. Their project involvement spans biomedical research on thrombosis (TAPAS) and neuroscience training programs using zebrafish models (ZENITH), indicating their imaging technology is applicable to both vascular biology and live in-vivo neural circuit visualization. As a private company operating at the intersection of optical instrumentation and research biology, they serve academic labs requiring imaging tools beyond standard commercial offerings.

What they specialise in

How they've shifted over time

In their first H2020 project (TAPAS, from 2018), the organization contributed to biomedical thrombosis research without generating any recorded keywords — consistent with a general imaging infrastructure role rather than a scientific lead. By 2019 and the ZENITH project, a far more specific profile emerged: zebrafish neuroscience, neural circuits, sensory-motor integration, and data-driven modelling. This trajectory points from broad biomedical imaging toward a defined niche in live-animal neuroscience imaging with a growing computational dimension.

They appear to be moving deeper into neuroscience-specific live imaging, particularly with zebrafish models, while simultaneously expanding toward data-driven computational approaches that complement their optical instrumentation.

How they like to work

This organization participates exclusively as a third-party contributor — never as a coordinator or formal beneficiary — which is consistent with a technology supplier that hosts visiting researchers or provides specialized instruments to academic consortia without taking on management responsibility. Both participations were in large MSCA-ITN training networks (33 unique partners, 11 countries combined), meaning they interface with many research groups simultaneously while remaining structurally peripheral to consortium governance. For a project coordinator, this makes them straightforward to engage as a specialist resource with predictable scope and limited administrative overhead.

Despite only two projects, they have accumulated connections with 33 unique consortium partners across 11 countries — a broad footprint that reflects the large multi-institution structure typical of MSCA-ITN training networks. Their geographic exposure is pan-European, concentrated in research-intensive countries common to Marie Skłodowska-Curie consortia.

What sets them apart

As a private SME from Göttingen — a city with a strong scientific instrument heritage — they bring commercial-grade imaging expertise into academic research training networks, a combination rarely found among the predominantly university-based members of MSCA consortia. Their third-party participation model means they can contribute specialized capability to multiple European research groups simultaneously without the administrative burden of consortium coordination. For a consortium builder needing a credible industry imaging partner with established relationships in neuroscience and biomedical networks, they represent a low-friction addition.

Highlights from their portfolio

• ZENITH
  A five-year MSCA-ITN program (2019-2024) on zebrafish neuroscience training that generated the organization's entire known keyword profile — neural circuits, sensory-motor integration, data-driven models — and represents their deepest documented research engagement.
• TAPAS
  Their H2020 entry point via a thrombosis-focused MSCA-ITN (2018-2022), showing early cross-disciplinary positioning as an imaging contributor in vascular biology before pivoting toward neuroscience.